Completed
Phase 4 Study of Speeda® Rabies Vaccinia That Use for Protection the Crowd Bitten by Animals to Three-level
What is being tested
rabies vaccine
Biological
Who is being recruted
+5 Eligibility Criteria
How is the trial designed
Prevention Study
Phase 4
Interventional
Study Start: February 2013
Summary
Principal SponsorBeijing Center for Disease Control and Prevention
Last updated: January 20, 2016
Sourced from a government-validated database.Claim as a partner
Study start date: February 1, 2013
Actual date on which the first participant was enrolled.When found the injury who is bitten by the animal to three-level, the investigators would enroll the participant after explaining the protection and making him signed the informed consent. The patient would inject rabies vaccine as follow the national regulation, meanwhile the investigators would get the blood samples to detect whether the man-killer carries the rabies virus.
Principal SponsorBeijing Center for Disease Control and Prevention
Last updated: January 20, 2016
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
37 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
3 inclusion criteria required to participate
Parent/legal acceptable representatives of children or the adult participants are willing and able to understand the protocol requirements and provide informed consent signed
Participant is considered to be in good health including the body and mental status on the basis of reported medical history and limited physical examination and live in local >= 12 months before injured
The man-killer could found and detect whether it carries the virus
2 exclusion criteria prevent from participating
Apply passive immunity preparation
Known bleeding disorder or suspected impairment of immunologic function, or receipt of immunosuppressive therapy or immunoglobulin since birth
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalWhen injured by the animal who carries the rabies virus, the patient after standard treatment would survive or die
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Hunan Centers for Disease Control and Prevention
Changsha, ChinaOpen Hunan Centers for Disease Control and Prevention in Google MapsCompletedOne Study Center